Improved cancer patient care driven by data

We are contributing to this work by:

Developing

innovative molecular tests, for identifying the characteristics of the tumor.

Collecting and storing

knowledge of and information about the patient and their tumor.

Integrating

the information and knowledge with treatment outcome to accelerate scientific research. This enables us to learn from the data of today’s patients and provide better treatment for the patients of tomorrow.

Vrouw en man spreken in behandelkamer met vrouwelijke arts, zittend aan een overlegtafel

Share your data

Your contribution to improving the treatment of tomorrow’s patients is important. Share your data, too!

Read more

Share your data and share our vision for the future of cancer diagnosis

Read the latest news

Health ReWireD accelerates personalized care for patients with cancer

Health ReWireD accelerates personalized care for patients with cancer

12-11-2026

Health ReWireD demonstrates how we can better utilize data to provide tailored care to patients. For this to happen, the …

A Learning Healthcare System for Better Cancer Research and Care 

A Learning Healthcare System for Better Cancer Research and Care 

02-11-2026

Vast amounts of data are generated during cancer diagnosis and treatment every single day. Tissue samples are analyzed, data about …

Requesting data from Hartwig Medical Foundation is now easier

Requesting data from Hartwig Medical Foundation is now easier

08-10-2026

As of September 1, 2026, the procedure for requesting data from the Hartwig Medical Database has been simplified. With this …

Metastatic bladder cancer: new insights into tumour spread and chemotherapy resistance

Metastatic bladder cancer: new insights into tumour spread and chemotherapy resistance

25-09-2026

Hartwig data supports new Nature study on lethal metastatic bladder cancer. Researchers used the Hartwig Medical Database to independently validate …

Why genomes need clinical data: new Nature study uses Hartwig real world data to test a prostate cancer biomarker

Why genomes need clinical data: new Nature study uses Hartwig real world data to test a prostate cancer biomarker

25-09-2026

Understanding prostate cancer’s clinical heterogeneity A new study in Nature investigates the mutational processes behind prostate cancer’s clinical heterogeneity and …

Hartwig advances precision oncology worldwide with oncoanalyser

Hartwig advances precision oncology worldwide with oncoanalyser

07-09-2026

Nicole Schonrock on scaling precision care for patients with cancer in Australia Hartwig Medical Foundation has developed powerful software for …

Read all our news

Read the latest blogs

Expansion of the Hartwig Client Portal: registration becomes easier, safer, and smarter

Expansion of the Hartwig Client Portal: registration becomes easier, safer, and smarter

07-08-2026

The expansion of the Hartwig Client Portal marks another important step in further digitizing the collaboration between Hartwig Medical Foundation …

Read more
DataNexus connects clinical and genomic data

DataNexus connects clinical and genomic data

12-05-2026

DataNexus is a project initiated by the Netherlands Cancer Institute–Antoni van Leeuwenhoek (NKIAvL) to improve data availability by integrating clinical …

Read more
How do you analyze 8,000 Tumor/Normal genomes in under two months?

How do you analyze 8,000 Tumor/Normal genomes in under two months?

06-03-2026

It has been a long time coming: Hartwig Medical Foundation has transitioned to the GRCh38 (hg38) reference genome! For years, …

Read more
Read all our blogs

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl